title: CSF noradrenergic activity and sleep EEG in clinically stable schizophrenic patients after haloperidol withdrawal.
authors.affiliation: Highland Drive VAMC, Pittsburgh, PA 15206.
authors.forename: D P
authors.initials: DP
authors.lastname: van Kammen
authors.forename: J
authors.initials: J
authors.lastname: Yao
authors.forename: J
authors.initials: J
authors.lastname: Gurklis
authors.forename: D
authors.initials: D
authors.lastname: O'Connor
authors.forename: E
authors.initials: E
authors.lastname: Nofzinger
authors.forename: J L
authors.initials: JL
authors.lastname: Peters
mesh_terms: D000328:Adult; D004299:Dopamine beta-Hydroxylase / Q000134:cerebrospinal fluid; D004569:Electroencephalography; D006220:Haloperidol; D006801:Humans; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid; D008875:Middle Aged; D009638:Norepinephrine / Q000134:cerebrospinal fluid*; D012559:Schizophrenia / Q000134:cerebrospinal fluid*; D012890:Sleep / Q000502:physiology*; D012895:Sleep, REM / Q000502:physiology; D013375:Substance Withdrawal Syndrome / Q000134:cerebrospinal fluid*
chemical_list: D008734:Methoxyhydroxyphenylglycol; D004299:Dopamine beta-Hydroxylase; D006220:Haloperidol; D009638:Norepinephrine